Search alternatives:
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
ng decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
10 mg » 10 mm (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
ng decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
10 mg » 10 mm (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Long-term treatment with rapamycin results in decrease in progenitor cells.
Published 2015“…Quantitative calculation of DCX-positive cells per field in different groups. Rats treated with 1.0 and 3.0 mg/kg rapamycin demonstrated decrease in DCX-positive cells. …”
-
8
Long-term treatment with rapamycin results in decrease in cellular immune factors.
Published 2015“…No obvious change was noted among different groups in Il-1β both in brain and blood (A,B). IL-2 was decreased with 1.0 and 3.0 mg/kg rapamycin treatment both in brain and blood (C, D). …”
-
9
Decreasing ShcA expression enhances TGF-β-induced Smad signaling.
Published 2015“…(D, E) Decreasing ShcA expression, upon transfection of ShcA siRNA (siShc-a for NMuMG cells, siShc-c for HaCaT cells) but not control siRNA, enhances Smad3-mediated transcription, quantified by luciferase expression from a 4xSBE-luciferase reporter, in NMuMG (D) and HaCaT (E) cells, in the absence of or in response to 0.8 ng/ml TGF-β, or treated with SB431542, for 6 h. …”
-
10
-
11
-
12
Decreased Rab10 localization in raft fractions following methamphetamine treatment.
Published 2015Subjects: -
13
Decreased ShcA expression promotes EMT in NMuMG and HaCaT cells.
Published 2015“…<p>(A) ShcA levels, assessed by immunoblotting, in NMuMG and HaCaT cells transfected with ShcA or control siRNA. siShc-a and siShc-b are ShcA siRNAs used in NMuMG cells, and siShc-c and siShc-d are used in HaCaT cells. …”
-
14
-
15
-
16
-
17
-
18
Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints.
Published 2020“…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
-
19
-
20